B
Bloom Science
Bloom Science – Developing innovative therapies focused on microbiome gut–brain axis.
About Bloom Science
Bloom Science is a clinical-stage biotechnology company that develops treatments for neurological disorders. The company's approach is centered on the gut-brain axis, using live biotherapeutic products (LBPs) to modulate the microbiome and influence neurological health.
Their main program, BL-001, is being developed for conditions like Dravet syndrome and other forms of epilepsy. The company is also exploring treatments for other complex neurological conditions, including Amyotrophic Lateral Sclerosis (ALS), through partnerships with research institutions like the Weizmann Institute of Science. Bloom Science's business model involves discovering, developing, and commercializing these novel therapies. They serve patients with rare and complex neurological disorders, a market with significant unmet medical needs.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- San Diego, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 70.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2021 | $12M | $48M | Apollo Health Ventures · Joyance Partners · ALS Investment Fund · Leaps by Bayer | ↗ |
| OtherOther financing | Mar 2020 | $0 | — | Joyance Partners · Social Starts | — |
Growth signals
Latest recorded traffic for Bloom Science is 2.1K monthly website visits, up 40% over the last three months. Bloom Science's team declined 5.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Social Starts
Series A5 investors entered at this stage
ALS Investment Fund
Leaps by Bayer
Apollo Health Ventures
Joyance Partners
Bayer
Other known investors3 additional known investors
University of California, Los Angeles
PsyMed Ventures
PsyMed Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bloom Science on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bloom Science’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.